<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="[OANC]/data/written_2/technical/plos/pmed.0010026.anc" start="3300" end="3304" sStart="3242" offset="58" sid="r7.poor.j.0817" wn="5" wnkey="poor%5:00:00:insufficient:00" annotator="veweser" text="These characteristics are the likely cause of the poor immune reaction generated by these peptides [5]." />
    <s path="[OANC]/data/written_2/technical/plos/pmed.0010026.anc" start="3300" end="3304" sStart="null" offset="58" sid="r7.poor.j.0817" wn="4" wnkey="poor%3:00:02::" annotator="jeneale" text="These characteristics are the likely cause of the poor immune reaction generated by these peptides [5]." />
    <s path="[OANC]/data/written_2/technical/plos/pmed.0010026.anc" start="2250" end="2256" sStart="null" offset="138" sid="r9.normal.j.0837" wn="1" wnkey="normal%3:00:01::" annotator="veweser" text="Most of the peptides identified so far are either normal self proteins aberrantly expressed in cancer but not in most other adult normal tissues or tissue-specific antigens also expressed in certain types of cancer." />
    <s path="[OANC]/data/written_2/technical/plos/pmed.0010026.anc" start="5541" end="5547" sStart="null" offset="223" sid="r9.normal.j.0364" wn="1" wnkey="normal%3:00:01::" annotator="brubin" text="These results emphasize how difficult it is to translate findings, such as the spectacular results obtained by the vaccination of TCR transgenic mice with heteroclitic peptides [12], into an application for normal animals and humans." />
    <s path="file:/c:/OANC/data/written_2/technical/plos/pmed.0010026.anc" start="2030" end="2034" sStart="null" offset="0" sid="null" wn="2" wnkey="long%3:00:01::" annotator="rstandig" text="Now, however, a &lt;b&gt;long&lt;/b&gt; list of more or less tumor-specific antigens has been generated [3]." />
    <s path="[OANC]/data/written_2/technical/plos/pmed.0010026.anc" start="1361" end="1365" sStart="null" offset="114" sid="r7.1.easy.j.0897" wn="1" wnkey="easy%3:00:01::" annotator="veweser" text="Short synthetic peptides are ideal for drug development because of the relatively low cost of production, easy storage, and high safety." />
  </sentences>
</list>